170 related articles for article (PubMed ID: 18218578)
21. The evolution of Taiwan's National Health Insurance drug reimbursement scheme.
Hsu JC; Lu CY
Daru; 2015 Feb; 23(1):15. PubMed ID: 25889754
[TBL] [Abstract][Full Text] [Related]
22. Estimating the lifelong health impact and financial burdens of different types of lung cancer.
Yang SC; Lai WW; Su WC; Wu SY; Chen HH; Wu YL; Hung MC; Wang JD
BMC Cancer; 2013 Dec; 13():579. PubMed ID: 24308346
[TBL] [Abstract][Full Text] [Related]
23. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates.
Chu PC; Wang JD; Hwang JS; Chang YY
Value Health; 2008 Dec; 11(7):1102-9. PubMed ID: 18489497
[TBL] [Abstract][Full Text] [Related]
24. Household out-of-pocket medical expenditures and National Health Insurance in Taiwan: income and regional inequality.
Chu TB; Liu TC; Chen CS; Tsai YW; Chiu WT
BMC Health Serv Res; 2005 Sep; 5():60. PubMed ID: 16137336
[TBL] [Abstract][Full Text] [Related]
25. Incidence, prevalence, and medical expenditures of classical amyotrophic lateral sclerosis in Taiwan, 1999-2008.
Tsai CP; Wang KC; Hwang CS; Lee IT; Lee CT
J Formos Med Assoc; 2015 Jul; 114(7):612-9. PubMed ID: 26154753
[TBL] [Abstract][Full Text] [Related]
26. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
27. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
Chen PC; Lee JC; Wang JD
PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
[TBL] [Abstract][Full Text] [Related]
28. An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan.
Chang HY; Weiner JP
BMC Med; 2010 Jan; 8():7. PubMed ID: 20082689
[TBL] [Abstract][Full Text] [Related]
29. Lifetime risks, expected years of life lost, and cost-per-life year of esophageal cancer in Taiwan.
Lai WW; Lin CN; Chang CC; Wang JD
Sci Rep; 2020 Feb; 10(1):3722. PubMed ID: 32111930
[TBL] [Abstract][Full Text] [Related]
30. Reflections on the 20th anniversary of Taiwan's single-payer National Health Insurance System.
Cheng TM
Health Aff (Millwood); 2015 Mar; 34(3):502-10. PubMed ID: 25732502
[TBL] [Abstract][Full Text] [Related]
31. Lifetime Risks, Life Expectancy, and Health Care Expenditures for Rheumatoid Arthritis: A Nationwide Cohort Followed Up From 2003 to 2016.
Chiu YM; Lu YP; Lan JL; Chen DY; Wang JD
Arthritis Rheumatol; 2021 May; 73(5):750-758. PubMed ID: 33295139
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of carrier and prenatal genetic testing for X-linked hemophilia.
Tsai MC; Cheng CN; Wang RJ; Chen KT; Kuo MC; Lin SJ
J Formos Med Assoc; 2015 Aug; 114(8):722-8. PubMed ID: 23932837
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
34. Use of cognitive enhancers and associated medical care costs among patients with dementia: a nationwide study in Taiwan.
Ku LJ; Pai MC
Int Psychogeriatr; 2014 May; 26(5):795-804. PubMed ID: 24429098
[TBL] [Abstract][Full Text] [Related]
35. Healthcare utilization and expenditure among individuals with end-stage kidney disease in Taiwan.
Lee CC; Hsu CC; Lin MH; Sung JM; Kuo TH
J Formos Med Assoc; 2022 Feb; 121 Suppl 1():S47-S55. PubMed ID: 34980549
[TBL] [Abstract][Full Text] [Related]
36. Sustainability of recurrent expenditure on public social welfare programmes: expenditure analysis of the free maternal care programme of the Ghana National Health Insurance Scheme.
Ankrah Odame E; Akweongo P; Yankah B; Asenso-Boadi F; Agyepong I
Health Policy Plan; 2014 May; 29(3):271-9. PubMed ID: 23543198
[TBL] [Abstract][Full Text] [Related]
37. Incidence of cancer in children aged 0-14 years in Taiwan, 1996-2010.
Liu YL; Lo WC; Chiang CJ; Yang YW; Lu MY; Hsu WM; Ho WL; Li MJ; Miser JS; Lin DT; Lai MS
Cancer Epidemiol; 2015 Feb; 39(1):21-8. PubMed ID: 25599927
[TBL] [Abstract][Full Text] [Related]
38. Explanatory ability of the ACG system regarding the utilization and expenditure of the national health insurance population in Taiwan--a 5-year analysis.
Lee WC; Huang TP
J Chin Med Assoc; 2008 Apr; 71(4):191-9. PubMed ID: 18436502
[TBL] [Abstract][Full Text] [Related]
39. Apply influence diagrams for utility analysis of paying the weight-reducing expenses: a case study in taiwan.
Wu F; Sun PR; Chang CC
J Med Syst; 2011 Feb; 35(1):105-11. PubMed ID: 20703580
[TBL] [Abstract][Full Text] [Related]
40. Lifetime costs of the top five cancers in Taiwan.
Lang HC; Wu SL
Eur J Health Econ; 2012 Jun; 13(3):347-53. PubMed ID: 21442437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
